Literature DB >> 9098722

Purification and characterization of defensins from cystic fibrosis sputum.

L B Soong1, T Ganz, A Ellison, G H Caughey.   

Abstract

OBJECTIVE AND
DESIGN: Cystic fibrosis (CF) sputum contains large numbers of neutrophils whose most abundant granule proteins are defensins. Within phagolysosomes, defensins kill microbes; however, extracellular defensins can be toxic to human cells. To begin to explore the possibility that defensins damage CF airways, this study examines the concentration and properties of defensins in CF sputum. MATERIALS: As a source of biological material in which to assay levels of defensins, purulent sputum was collected from persons with CF hospitalized with exacerbations of bronchitis. Purulent CF sputum was also a source of material for purification of defensins.
METHODS: Defensin concentration in the cell-free component of CF sputum was measured by immunoassay. Defensins acid-extracted from sputum were purified by Sephacryl S-200 gel filtration chromatography and reverse phase-high pressure liquid chromatography (HPLC). Toxicity of CF defensins was tested by incubating the purified defensins with a line of CF tracheal cells cultured in serum five medium.
RESULTS: In 5 patients with CF, sputum defensin levels ranged from 300 to > 1600 micrograms/ml, higher than levels previously reported in any human secretion or fluid and greatly exceeding concentrations toxic to mammalian cells in vitro. HPCL-purified CF sputum defensins were pure as judged by acid urea-PAGE and N-terminal sequencing, which revealed a mixture of defensins-1, -2 and -3 at ratios of approximately 4:2:1. At > 10 micrograms/ml the purified mixture was toxic for a line of CF tracheal cells cultured in serum-free medium, as judged by reductions in cell numbers and increased permeability to trypan blue.
CONCLUSIONS: This study suggests that defensins in CF sputum are intact and sufficiently abundant that they may damage airway epithelium.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9098722     DOI: 10.1007/s000110050114

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  25 in total

1.  Dynamic changes in neutrophil defensins during endotoxemia.

Authors:  M E Klut; B A Whalen; J C Hogg
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

Review 2.  Antimicrobial polypeptides in host defense of the respiratory tract.

Authors:  Tomas Ganz
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

3.  Nonenzymatic conversion of ADP-ribosylated arginines to ornithine alters the biological activities of human neutrophil peptide-1.

Authors:  Linda A Stevens; Joseph T Barbieri; Grzegorz Piszczek; Amy N Otuonye; Rodney L Levine; Gang Zheng; Joel Moss
Journal:  J Immunol       Date:  2014-11-12       Impact factor: 5.422

Review 4.  Antimicrobial peptides: current status and therapeutic potential.

Authors:  Andreas R Koczulla; Robert Bals
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 5.  Transepithelial migration of neutrophils: mechanisms and implications for acute lung injury.

Authors:  Rachel L Zemans; Sean P Colgan; Gregory P Downey
Journal:  Am J Respir Cell Mol Biol       Date:  2008-10-31       Impact factor: 6.914

Review 6.  Contribution of neutrophils to acute lung injury.

Authors:  Jochen Grommes; Oliver Soehnlein
Journal:  Mol Med       Date:  2010-10-18       Impact factor: 6.354

7.  The Staphylococcus aureus two-component regulatory system, GraRS, senses and confers resistance to selected cationic antimicrobial peptides.

Authors:  Soo-Jin Yang; Arnold S Bayer; Nagendra N Mishra; Michael Meehl; Nagender Ledala; Michael R Yeaman; Yan Q Xiong; Ambrose L Cheung
Journal:  Infect Immun       Date:  2011-10-10       Impact factor: 3.441

8.  Comprehensive defensin assay for saliva.

Authors:  Michael S Gardner; Megan D Rowland; Amy Y Siu; Jonathan L Bundy; Diane K Wagener; James L Stephenson
Journal:  Anal Chem       Date:  2009-01-15       Impact factor: 6.986

9.  Human neutrophil peptides and phagocytic deficiency in bronchiectatic lungs.

Authors:  Stefanos Voglis; Kieran Quinn; Elizabeth Tullis; Mingyao Liu; Melanie Henriques; Celia Zubrinich; Oscar Peñuelas; Holman Chan; Frances Silverman; Vera Cherepanov; Neil Orzech; Aye Aye Khine; André Cantin; Arthur S Slutsky; Gregory P Downey; Haibo Zhang
Journal:  Am J Respir Crit Care Med       Date:  2009-04-30       Impact factor: 21.405

10.  Neutrophil alpha-defensins cause lung injury by disrupting the capillary-epithelial barrier.

Authors:  Khalil Bdeir; Abd Al-Roof Higazi; Irina Kulikovskaya; Melpo Christofidou-Solomidou; Sergei A Vinogradov; Timothy C Allen; Steven Idell; Rose Linzmeier; Tomas Ganz; Douglas B Cines
Journal:  Am J Respir Crit Care Med       Date:  2010-01-21       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.